Lonza’s branded L-carnitine granted pet food patent, supports performance and recovery of active dogs
Lonza (Greenwood, SC) has been granted U.S. Patent 10,016,382 for its L-carnitine’s use in pet food to support performance and recovery in active dogs.
Lonza (Greenwood, SC) has been granted U.S. Patent 10,016,382 for its L-carnitine’s use in pet food to support performance and recovery in active dogs. L-carnitine reduces muscle degradation and oxidative stress from intense physical activity, helping to maintain lean muscle mass. The patent confirms evidence that small daily doses of Lonza’s branded L-carnitine, Carniking, may enhance the quality of life and function of active dogs and working animals such as service dogs and tracking dogs.
“Bringing together 30 years of investment and discovery in L-carnitine, Lonza’s new patent for L-carnitine as Carniking highlights our continued commitment to exploring its health benefits for both animals and humans,” said Kevin Owen, PhD, global business development head- companion animals at Lonza CHN and co-author of the patent, in a press release. “Backed by robust science, the patent confirms that L-carnitine is good for both you and for your dog.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
